Immunization, HepB3 in East Asia & Pacific
East Asia & Pacific: Immunization, HepB3 was 87.9% in 2024. ◆ Volatile
Immunization, HepB3 in East Asia & Pacific, 1985–2024
Source: World Health Organization (WHO). Measured in % of one-year-old children.
Analysis
The most recent figure for immunization, hepb3 in East Asia & Pacific is 87.9%, measured in 2024.
That represents a change of down 0.6% on the previous year and down 3.9% over ten years.
Over the whole period, immunization, hepb3 in East Asia & Pacific peaked at 93.8% in 2019 and was at its lowest, 0.0%, in 1985.
East Asia & Pacific ranks 15th of 47 groups on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, HepB3 in East Asia & Pacific, year by year
| Year | % of one-year-old children | Change |
|---|---|---|
| 1985 | 0.0% | — |
| 1986 | 0.0% | — |
| 1987 | 0.0% | — |
| 1988 | 0.0% | — |
| 1989 | 0.8% | — |
| 1990 | 1.2% | +47.0% |
| 1991 | 1.3% | +3.7% |
| 1992 | 5.1% | +304.6% |
| 1993 | 8.9% | +74.3% |
| 1994 | 9.5% | +6.9% |
| 1995 | 16.2% | +71.6% |
| 1996 | 18.0% | +11.0% |
| 1997 | 18.5% | +2.8% |
| 1998 | 20.4% | +10.1% |
| 1999 | 21.2% | +3.8% |
| 2000 | 50.3% | +137.5% |
| 2001 | 56.1% | +11.5% |
| 2002 | 58.6% | +4.5% |
| 2003 | 66.5% | +13.4% |
| 2004 | 70.9% | +6.6% |
| 2005 | 74.7% | +5.4% |
| 2006 | 82.2% | +10.1% |
| 2007 | 84.0% | +2.2% |
| 2008 | 87.8% | +4.6% |
| 2009 | 90.8% | +3.4% |
| 2010 | 90.8% | -0.0% |
| 2011 | 89.6% | -1.3% |
| 2012 | 90.9% | +1.4% |
| 2013 | 90.1% | -0.9% |
| 2014 | 91.5% | +1.6% |
| 2015 | 90.8% | -0.8% |
| 2016 | 91.5% | +0.7% |
| 2017 | 91.3% | -0.2% |
| 2018 | 90.5% | -0.9% |
| 2019 | 93.8% | +3.6% |
| 2020 | 92.0% | -1.9% |
| 2021 | 86.4% | -6.1% |
| 2022 | 93.0% | +7.7% |
| 2023 | 88.5% | -4.9% |
| 2024 | 87.9% | -0.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 0.2% | 0.0% | 0.8% | 5 |
| 1990s | 12.0% | 1.2% | 21.2% | 10 |
| 2000s | 72.2% | 50.3% | 90.8% | 10 |
| 2010s | 91.1% | 89.6% | 93.8% | 10 |
| 2020s | 89.6% | 86.4% | 93.0% | 5 |
More health data for East Asia & Pacific
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, annual growth rate 1.66 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.0351 units per person (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, annual growth rate 1.4 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.0412 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate 2.45 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0386 units per person (2025)
- Population ages 30-34, female, annual growth rate -4.35 % change on previous year (2025)
Frequently asked questions
- What is immunization, hepb3 in East Asia & Pacific?
- Immunization, hepb3 in East Asia & Pacific was 87.9% in 2024, according to World Health Organization (WHO).
- What is the highest immunization, hepb3 recorded in East Asia & Pacific?
- The highest recorded value was 93.8% in 2019.
- What is the lowest immunization, hepb3 recorded in East Asia & Pacific?
- The lowest recorded value was 0.0% in 1985.
- How does East Asia & Pacific rank for immunization, hepb3?
- East Asia & Pacific ranks 15th out of 47 groups with data for 2024.
- Is immunization, hepb3 rising or falling in East Asia & Pacific?
- Over the last ten years it is down 3.9%. The long-run trend across the full record is volatile.
- Where does this East Asia & Pacific data come from?
- The figures come from World Health Organization (WHO), published as part of Immunization, HepB3 (% of one-year-old children). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 40 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.